» Articles » PMID: 24976103

The Prevalence of Parkinson's Disease: a Systematic Review and Meta-analysis

Overview
Journal Mov Disord
Date 2014 Jul 1
PMID 24976103
Citations 776
Authors
Affiliations
Soon will be listed here.
Abstract

Parkinson's Disease (PD) is a common neurodegenerative disorder. We sought to synthesize studies on the prevalence of PD to obtain an overall view of how the prevalence of this disease varies by age, by sex, and by geographic location. We searched MEDLINE and EMBASE for epidemiological studies of PD from 1985 to 2010. Data were analyzed by age group, geographic location, and sex. Geographic location was stratified by the following groups: 1) Asia, 2) Africa, 3) South America, and 4) Europe/North America/Australia. Meta-regression was used to determine whether a significant difference was present between groups. Forty-seven studies were included in the analysis. Meta-analysis of the worldwide data showed a rising prevalence of PD with age (all per 100,000): 41 in 40 to 49 years; 107 in 50 to 59 years; 173 in 55 to 64 years; 428 in 60 to 69 years; 425 in 65 to 74 years; 1087 in 70 to 79 years; and 1903 in older than age 80. A significant difference was seen in prevalence by geographic location only for individuals 70 to 79 years old, with a prevalence of 1,601 in individuals from North America, Europe, and Australia, compared with 646 in individuals from Asia (P < 0.05). A significant difference in prevalence by sex was found only for individuals 50 to 59 years old, with a prevalence of 41 in females and 134 in males (P < 0.05). PD prevalence increases steadily with age. Some differences in prevalence by geographic location and sex can be detected.

Citing Articles

Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances.

Jiang Q, Liu J, Huang S, Wang X, Chen X, Liu G Signal Transduct Target Ther. 2025; 10(1):76.

PMID: 40059211 PMC: 11891338. DOI: 10.1038/s41392-025-02145-7.


An analysis of curative care expenditure for Parkinson's disease under different comorbidity conditions: an empirical study based on China.

Zhou Y, Li Y, Li J, Wei Q, Fan L, Zhang X BMC Geriatr. 2025; 25(1):159.

PMID: 40055585 PMC: 11889760. DOI: 10.1186/s12877-025-05790-3.


Exercise Ameliorates Dysregulated Mitochondrial Fission, Mitochondrial Respiration, and Neuronal Apoptosis in Parkinson's Disease Mice via the Irisin/AMPK/SIRT1 Pathway.

Li N, Wang B, Wang Y, Tian X, Lin J, Sun X Mol Neurobiol. 2025; .

PMID: 40048058 DOI: 10.1007/s12035-025-04801-z.


Projections for prevalence of Parkinson's disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021.

Su D, Cui Y, He C, Yin P, Bai R, Zhu J BMJ. 2025; 388:e080952.

PMID: 40044233 PMC: 11881235. DOI: 10.1136/bmj-2024-080952.


Preclinical studies and transcriptome analysis in a model of Parkinson's disease with dopaminergic ZNF746 expression.

Kim J, Yang S, Kim H, Vo D, Maeng H, Jo A Mol Neurodegener. 2025; 20(1):24.

PMID: 40022229 PMC: 11871723. DOI: 10.1186/s13024-025-00814-3.